RCM
GSK icon

Requisite Capital Management’s GSK GSK Stock Holding History

Requisite Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-619
Closed -$32K – 140
2019
Q1 		$32K Buy
+619
New +$30.9K 0.01% 131

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Requisite Capital Management's GSK Position: Q2 2019 in Review

Requisite Capital Management sold out of GSK (GSK) in Q2 2019, closing a stake of 619 shares — an estimated $32K sold.

Requisite Capital Management first reported a position in GSK in Q1 2019 and held it in 1 quarter. The position peaked at $32K in Q1 2019. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

  • Requisite Capital Management reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
  • Requisite Capital Management sold 619 GSK shares in Q2 2019, an estimated $32K.
  • Requisite Capital Management first reported a position in GSK in Q1 2019 and held it in 1 quarter.
  • Requisite Capital Management's GSK position peaked at $32K in Q1 2019.
  • 804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Requisite Capital Management's 13F filing for Q2 2019, filed 5 Aug 2019.